Norepinephrine involvement in antidepressant action

Journal of Clinical Psychiatry

Volumn 61, Issue SUPPL. 10, 2000, Pages 25-30

  Frazer, Alan ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; CITALOPRAM; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE MALEATE; MIRTAZAPINE; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VENLAFAXINE;

BEHAVIOR; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HUMAN; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; REVIEW;

ADRENERGIC UPTAKE INHIBITORS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DESIPRAMINE; HUMANS; NOREPINEPHRINE; SEROTONIN UPTAKE INHIBITORS; SYNAPTIC TRANSMISSION;

EID: 0033930407     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. De Boer T, Maura G, Raiteri M, et al. Neurochemical and autonomic pharmacological profiles of the 6-AZA-analogue of mianserin. ORG 3770 and its enantiomers. Neuropharmacology 1988;27:399-408
2. Richelson E. Biological basis of depression and therapeutic relevance. J Clin Psychiatry 1991;52(6, suppl):4-10
3. Bolden-Watson C, Richelson E. Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 1993; 52:1023-1029
4. Hyttel J, Larsen J-J. Serotonin-selective antidepressants. Acta Pharmacol Toxicol 1985;56(1, suppl):146-161
5. Melloni P, Carniei G, Della Torre A, et al. Potential antidepressant agents: α-aryloxybenzyl derivatives of ethanolamine and morpholine. Eur J Med Chem 1984;19:235-242
6. Bowden CL, Koslow SH, Hanin I, et al. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid. Clin Pharmacol Ther 1985;37:316-324
7. 2-adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain. J Pharmacol Exp Ther 1996;277:861-871
8. Baraban JM, Aghajanian GK. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 1980;19:355-363
9. Ascher JA, Cole J-N, Colin JA, et al. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995;56:395-401
10. Golden RN, Rudorfer MV, Sherer MA, et al. Bupropion in depression, I: biochemical effects and clinical response. Arch Gen Psychiatry 1988;45: 139-143
11. Golden RN, DeVane CL, Laizure SC, et al. Bupropion in depression, II: the role of metabolites in clinical outcome. Arch Gen Psychiatry 1988;45: 145-149
12. Perumal AS, Smith TM, Suckow RF, et al. Effects of plasma from patients containing bupropion and its metabolites on the uptake of norepinephrine. Neuropharmacology 1986;25:199-202
13. Salazar DE, Chaikin PC, Swanson BN, et al. The effects of nefazodone and fluoxetine on platelet serotonin uptake and whole blood serotonin [abstract]. Clin Pharmacol Ther 1994;55:137
14. Cusack B, Nelson A, Richelson E. Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl) 1994;114:559-565
15. Quitkin FM, Rabkin JG, Ross D, et al. Identification of true drug response to antidepressants. Arch Gen Psychiatry 1984;41:782-786
16. Quitkin FM, McGrath PJ, Stewart JW, et al. Chronological milestones to guide drug change. Arch Gen Psychiatry 1996;53:785-792
17. Quitkin FM, McGrath PJ, Rabkin JG, et al. Different types of placebo response in patients receiving antidepressants. Am J Psychiatry 1991;148: 197-203
18. Katz MM, Koslow SH, Frazer A. Onset of antidepressant activity: reexamining the structure of depression and multiple action of drugs. Depress Anxiety 1996/1997;4:257-267
19. Montgomery SA. Are 2-week trials sufficient to indicate efficacy? Psychopharmacol Bull 1995;31:41-44
20. Mongeau R, Blier P, de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Rev 1997;23:145-195
21. Frazer A. Antidepressant drugs. Depression 1994;2:1-19
22. Pickel VM, Joh TH, Chan J, et al. Serotonergic terminals: ultrastructure and synaptic interaction with catecholamine-containing neurons in the medial nuclei of the solitary tracts. J Comp Neurol 1984;225:291-301
23. 2 adrenergic heteroreceptors of 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 1993;347:266-272
24. Frazer A, Pandey G, Mendels J, et al. The effect of tri-iodothyronine in combination with imipramine on [3H]-cyclic AMP production in slices of rat cerebral cortex. Neuropharmacology 1974;13:1311-1340
25. Vetulani J, Sulser F. Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature 1975;257:495-496
26. Banerjee SP, Kung LS, Riggi SJ, et al. Development of beta-adrenergic receptor subsensitivity by antidepressants. Nature 1977;268:455-456
27. Heninger GR, Charney DS. Mechanism of action of antidepressant treatments: implication for the etiology and treatment of depressive disorders. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987:535-544
28. Ordway GA, Gambarana C, Tejani-Butt SM, et al. Preferential reduction of binding of 1251-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments. J Pharmacol Exp Ther 1991;257:681-690
29. Hensler JG, Kovachich GB, Frazer A. A quantitative autoradiographic study of serotonin 1A receptor regulation: effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 1991;4: 131-144
30. Benmansour S, Cecchi M, Morilak D, et al. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci 1999;19:10494-10501
31. Delgado PL, Price LH, Miller HL. Rapid serotonin depletion as a provocative challenge test for patients with major depression: relevance to antidepressant action and the neurobiology of depression. Psychopharmacol Bull 1991;27:321-330
32. Miller HL, Delgado PL, Salomon RM, et al. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry 1996;53:117-128
33. Plotsky PM, Oswens MJ, Nemeroff CB. Neuropeptide alterations in mood disorders. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1995:971-981
34. Jones BE, Moore RY. Ascending projections of the locus ceruleus in the rat, II: autoradiographic study. Brain Res 1977;127:23-53
35. Jacobs BL, Abercrombie ED, Fornal CA, et al. Single-unit and physiological analyses of brain norepinephrine function in behaving animals. Prog Brain Res 1991;88:159-165
36. Jacobs BL. Central monoaminergic neurons: single-unit studies in behaving animals. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987:159-169
37. Foote SL, Aston-Jones G, Bloom FE. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc Natl Acad Sci U S A 1980;77:3033-3037
38. Aston-Jones G, Rajkowski J, Kubiak P, et al. Role of the locus coeruleus in emotional activation. Prog Brain Res 1996;107:380-402
39. Seiden NR, Cole BJ, Everitt BJ, et al. Damage to ceruleo-cortical noradrenergic projections impairs locally cued but enhances spatially cued water maze acquisition. Behav Brain Res 1990;39:29-51
40. Usher M, Cohen JD, Servan-Schreiber D, et al. The role of locus coeruleus in the regulation of cognitive performance. Science 1999;283:549-554
41. Woodward DJ, Moises HC, Waterhouse BD, et al. Modulatory actions of norepinephrine on neural circuits. Adv Exp Med Biol 1991;287:193-208
42. Waterhouse BD, Sessler FM, Cheng JT, et al. New evidence for a gating action of norepinephrine in central neuronal circuits of mammalian brain. Brain Res Bull 1988;21:425-432
43. Stafford IL, Jacobs BL. Noradrenergic modulation of the masseteric reflex in behaving cats, II: physiological studies. J Neurosci 1990;10:99-107
44. Morilak DA, Jacobs BL. Noradrenergic modulation of sensorimotor processes in intact rats: the masseteric reflex as a model system. J Neurosci 1985;5:1300-1306